Medikamentenvergleiche
Insulin Lispro vs. Exenatide
Insulin Lispro vs Exenatide for T2DM: Rapid-acting insulin vs GLP-1 agonist. Mealtime control vs glucose-dependent action and weight loss.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
This comparison arises when type 2 diabetes patients require injectable add-on therapy, choosing between mealtime insulin and a GLP-1 receptor agonist.
Fazit
Insulin Lispro excels in fast postprandial control while Exenatide provides weight benefits and lower hypoglycemia risk as a GLP-1 agonist.
Alle Medikamentenvergleiche